BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2019 9:57:12 AM | Browse: 1314 | Download: 3095
Publication Name World Journal of Gastroenterology
Manuscript ID 43097
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
Manuscript Source Unsolicited Manuscript
All Author List Hao Luo, Xia-Xia Zhang, Li-Hua Cao, Ning Tan, Qian Kang, Hong-Li Xi, Min Yu and Xiao-Yuan Xu
ORCID
Author(s) ORCID Number
Hao Luo http://orcid.org/0000-0002-2067-7217
Xia-Xia Zhang http://orcid.org/0000-0002-0512-9001
Li-Hua Cao http://orcid.org/0000-0002-4664-9003
Ning Tan http://orcid.org/0000-0001-9917-2192
Qian Kang http://orcid.org/0000-0001-5825-1660
Hong-Li Xi http://orcid.org/0000-0003-0389-7602
Min Yu http://orcid.org/0000-0001-7784-7830
Xiao-Yuan Xu http://orcid.org/0000-0002-1759-4330
Funding Agency and Grant Number
Funding Agency Grant Number
the 13th Five-Year Plan 2018ZX09206005-002
Corresponding Author Xiao-Yuan Xu, MD, Professor, Department of Infectious Diseases, Peking University First Hospital, Xishiku Street 8, Beijing 100034, China. xiaoyuanxu6@163.com
Key Words Chronic hepatitis B; Hepatitis B virus RNA; Virological response; HBeAg seroconversion; Entecavir
Core Tip HBeAg seroconversion was more likely to be achieved for chronic hepatitis B patients with hepatitis B virus (HBV) RNA levels below 4.12 log10 copies/mL before treatment. In the partial virological response group, serum HBV RNA showed an increasing trend.
Publish Date 2019-02-14 09:57
Citation Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728
URL https://www.wjgnet.com/1007-9327/full/v25/i6/719.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i6.719
Full Article (PDF) WJG-25-719.pdf
Full Article (Word) WJG-25-719.docx